<p>(A) LPS (1 μg /1 μl) or saline (1 μl) was locally injected into substantia nigra. Five days later, the mice were sacrificed. TH-positive nerve terminals in striatum were stained using immunohistochemistry, and (B) dopamine, (C) DOPAC and (D) HVA in striatum were measured by HPLC in WT and DJ-1 KO mice. (E) Turnover rates of dopamine in the striatum of WT and DJ-1 KO mice. The turnover rates were calculated by dividing summated levels of dopamine metabolites by corresponding levels of dopamine, and were used to evaluate the states of monoamine metabolism in dopaminergic neurons. Data were normalized as percentage of mean HPLC value in saline-treated WT mice (con) and presented as mean ± S.E.M. (n = 7 for each group) * p<0.05, Scale bar = ...
The manifestations of Parkinson’s disease are caused by reduced dopaminergic innervation of the stri...
<div><p><b>LPS in mice</b>. </p> <p>The levels of DA and its major metabolites DOPAC and HVA, as wel...
The fight against neurodegenerative diseases, including Parkinson’s disease (PD), is among the globa...
<p>Striata were microdissected from the brains of mice administered 90 days of saline (Ctrl), 1 mg/k...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
SummaryThe manifestations of Parkinson’s disease are caused by reduced dopaminergic innervation of t...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
The manifestations of Parkinson’s disease are caused by reduced dopaminergic innervation of the stri...
<div><p><b>LPS in mice</b>. </p> <p>The levels of DA and its major metabolites DOPAC and HVA, as wel...
The fight against neurodegenerative diseases, including Parkinson’s disease (PD), is among the globa...
<p>Striata were microdissected from the brains of mice administered 90 days of saline (Ctrl), 1 mg/k...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
The manifestations of Parkinson's disease are caused by reduced dopaminergic innervation of the stri...
SummaryThe manifestations of Parkinson’s disease are caused by reduced dopaminergic innervation of t...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
Early phases of Parkinson's disease (PD) are characterized by a mild reduction of dopamine (DA) in s...
The manifestations of Parkinson’s disease are caused by reduced dopaminergic innervation of the stri...
<div><p><b>LPS in mice</b>. </p> <p>The levels of DA and its major metabolites DOPAC and HVA, as wel...
The fight against neurodegenerative diseases, including Parkinson’s disease (PD), is among the globa...